Primary open-angle glaucoma. Glaucoma primary residual stage: capsular with pseudoexfoliation of lens . chronic simple . low-tension . pigmentary
Conditions
Interventions
Intervention 1: First group receive Timolol which is a non-specific blocker of beta-adrenergic receptor with concentration of 0.05%, twice daily for six weeks and also Latanoprost which is prostagland
Treatment - Drugs
First group receive Timolol which is a non-specific blocker of beta-adrenergic receptor with concentration of 0.05%, twice daily for six weeks and also Latanoprost which is prostaglandin with concentr
Second group receive Timolol which is a non-specific blocker of beta-adrenergic receptor with concentration of 0.05%, twice daily for six weeks and also Dorzolamide which is Henle's loop diuretic with
Sponsors
Arak University of Medical Science
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inclusion criteria: 1- Primary open angle gluacoma Exclusion criteria: 1- Secondary open angle glaucoma 2- Narrow-angle glaucoma 3- Allergy to trial drug 4- Ophthalmic herpes zoster 5- Pregnancy and lactation 6- Dry eyes that require use of ophtalmic drops is 5 times or more per day
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Decrease of intraocular pressure. Timepoint: In beginning of the study and the end of six weeks after treatment. Method of measurement: Goldmann Tonometry. | — |
Secondary
| Measure | Time frame |
|---|---|
| Failure of treatment. Timepoint: End of treatment. Method of measurement: Goldmann Tonometry.;Drug side effects. Timepoint: During study. Method of measurement: Clinical evaluation. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Reza Rezaei
Arak University of Medical Science
Outcome results
None listed